Procurement Director

OXB; England; On-site; GBP 70,000 - 90,000; Full time

Job summary

A leading organization in the biopharmaceutical sector, OXB, is seeking a Procurement Director to manage the procurement organization effectively. This pivotal role requires a strong leader who will be responsible for strategic sourcing and stakeholder engagement, driving innovations that contribute to the company's mission of delivering life-changing therapies. Candidates should possess relevant experience in procurement within regulated industries and hold at least a degree.

Benefits

Competitive total reward packages

Wellbeing programs

Career development opportunities

Inclusive and collaborative culture

State-of-the-art labs

Qualifications

• Proven history of working within procurement.
• Experience in pharmaceutical/biotech or tightly regulated industries.
• Ability to lead and develop teams.

Responsibilities

• Implement purchasing policies across all areas of the business.
• Build strong relationships with stakeholders and suppliers.
• Deliver end-to-end sourcing strategies.

Skills

Communication

Stakeholder Management

Data Analysis

Education

Degree level education

Job description

Job description:

Join Us in Changing Lives

AtOXB, our people are at the heart of everything we do. We’re on a mission to enable life-changing therapies to reach patients around the world—and we’re looking for passionate individuals who embody our core values every day:Responsible, Responsive, Resilient, and Respectful.

We are currently recruiting for a Procurement Director to manage the Procurement organisation. You will be ensuring effective and lean procurement processes and be responsible for delivering maximum value for money across our direct and indirect procurement spend, playing a key part in advancing our mission and making a real difference.

Our Procurement function ensures a strategic approach to the purchasing of good and services by driving effective and lean processes procurement processed, and to deliver maximum value for money across our direct and indirect procurement.

Your responsibilities in this role would be:

• Implement purchasing policies across all areas of the business.
• Ownership of a direct and indirect spend across all OXB functions.
• Develop and maintain stakeholder and key supplier relationships, both internally and externally at all levels in line with OXB values.
• Delivering innovation in procurement, streamlining the strategies, and adding value on major projects
• Managing long term pipelines for procurement, developing plans in line with the future goals of the organisation.
• Work cross functionally across OXB to ensure that the procurement process is maximizing value to the organisation.
• Work in collaboration with cross-functional stakeholder groups to develop & deliver sourcing best practices.
• Deliver end to end sourcing strategies helping transition the procurement team from transactional to a more a strategic function focusing on category management & SRM development.
• Build strong relationships across the business and with the supplier base, ensuring that business strategies are integrated into the procurement planning process.

Profile description:

We are looking for:

• Education to Degree level (or equivalent)
• An MCIPS qualification is desirable but not essential.
• A proven history of working within procurement, with evidence of both value adding and cost reduction via implementing effective sourcing strategies.
• Experience within pharmaceutical/biotech or other tightly regulated industries.
• Excellent communicator with the ability to engaging, building relationships, collaborate and influence with senior stakeholders both internally and externally.
• A people leader with experience of building, developing, and managing teams.
• The ability to create, analyse and drive data driven decisions.

About Us:

Oxford Biomedica is a quality and innovation-led viral vector CDMO (Contract Development and Manufacturing Organization) with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behindthe majority of gene therapies.

Oxford Biomedica collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus, and adenoviral vectors. Oxford Biomedica’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise.

Why Join Us?

• Competitive total reward packages
• Wellbeing programmesthat support your mental and physical health
• Career development opportunitiesto help you grow and thrive
• Supportive, inclusive, and collaborative culture
• State-of-the-art labs and manufacturing facilities
• A company that lives its values:Responsible, Responsive, Resilient, Respect

We want you to feel inspired every day. At OXB, we’re future-focused and growing fast. We succeed together—through passion, commitment, and teamwork.

Ready to Make a Difference?

Collaborate. Contribute. Change lives.

We offer:

Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.

Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).

Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.